Introduction The Herpes Zoster Drug Market is expected to register a CAGR of 6.9% from 2025 to 2031. Herpes Zoster, commonly known as shingles, is a viral infection caused by the varicella-zoster virus (VZV), the same virus responsible for chickenpox. It primarily affects older adults and individuals with weakened immune systems, leading to painful rashes, blisters, and neurological...